Tango Therapeutics, Inc. (TNGX)

CIK 1819133 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tango Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 202640001193125-26-447908
Nov 4, 202640001193125-26-447915
Nov 2, 20261440001950047-26-010577
Oct 23, 20268-K0001193125-26-429423
Oct 5, 202640001193125-26-414500
Sep 24, 202640001193125-26-401327
Sep 22, 20261440001950047-26-009747
Sep 3, 202640001193125-26-381853
Aug 14, 2026SCHEDULE 13G/A0001916761-26-000008
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005265
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352271
Aug 14, 2026SCHEDULE 13G0000886982-26-000510
Aug 14, 2026SCHEDULE 13G/A0000908834-26-000425
Aug 12, 2026SCHEDULE 13G/A0000919574-26-004954
Aug 11, 20268-K0001193125-26-344997
Aug 11, 20268-K0001193125-26-343434
Aug 11, 202610-Q0001193125-26-343424
Aug 11, 2026424B50001193125-26-344989
Aug 7, 20268-K/A0001193125-26-339070
Aug 6, 20268-K0001193125-26-338480
Aug 5, 202640001193125-26-335002
Aug 3, 20261440001950047-26-007562
Jul 2, 202640001193125-26-295124
Jun 23, 202630001193125-26-279866
Jun 23, 202640001193125-26-279871